Koyfin Home > Directory > Health Care > Boston Scientific Corp > Levered Free Cash Flow (FCF)

Boston Scientific Corp Levered Free Cash Flow (FCF) Chart (BSX)

Boston Scientific Corp annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Boston Scientific Corp Levered Free Cash Flow (FCF) for the quarter ending September 09, 2020 was $754m a -45.09% decrease of -340m year over year
  • Boston Scientific Corp Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2020 was $2,171m a 36.15% increase of 785m year over year
  • Boston Scientific Corp Annual Levered Free Cash Flow (FCF) for 2019 was $1,386m a 61.56% increase of 853m from 2018
  • Boston Scientific Corp Annual Levered Free Cash Flow (FCF) for 2018 was $533m a -134.25% decrease of -715m from 2017
  • Boston Scientific Corp Annual Levered Free Cash Flow (FCF) for 2017 was $1,248m a -98.98% decrease of -1,236m from 2016
Other Cash Flow Metrics:
  • Boston Scientific Corp Cash Flow from Operations for the quarter ending September 09, 2018 was $501m a -74.05% decrease of -371m year over year
  • Boston Scientific Corp Total Revenue for the quarter ending December 12, 2018 was $2,561m a 7.11% increase of 182m year over year
View Chart On Koyfin

Quarterly BSX Levered Free Cash Flow (FCF) Data

09/2020$754m
06/2020$408m
03/2020$-83m
12/2019$1,093m
09/2019$2,028m
06/2019$310m
03/2019$-2,044m
12/2018$184m
09/2018$473m
06/2018$-513m

Annual BSX Levered Free Cash Flow (FCF) Data

2019$1,386m
2018$533m
2017$1,248m
2016$2,484m
2015$973m
2014$1,427m
2013$985m
2012$985m
2011$1,270m
2010$519m